Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

The BioTech Breakthrough Award has been granted to Asahi Kasei for the Planova™ FG1 Filter

Head of Asahi Kasei Bioprocess. “Planova™ FG1 represents decades of filtration expertise and our continued commitment to helping manufacturers achieve higher efficiency without compromising safety.” With a water flux of 1,220 liters per square...

Odyssey Therapeutics Welcomes Dennis Dean, Ph.D., as EVP, Non-Clinical Development

discovery through IND* and into the clinic, Dennis is uniquely positioned to strengthen our non-clinical capabilities and help accelerate transformative medicines for patients.” Dr. Dean brings more than 25 years of experience spanning...

Gilead’s Livdelzi® Shows Sustained Efficacy in PBC, Reducing ALP, Relieving Itch, and Potentially Slowing Disease Progression

benefit observed in those at highest risk. This reinforces our belief in Livdelzi’s treatment profile and its potential to help transform care for people living with PBC. At Gilead, we remain focused on delivering innovation that drives long-term...

PRM Pharma Launches HemiClor® 12.5 mg, the First FDA-Approved Low-Dose Chlorthalidone Tablet for Hypertension

now available in pharmacies nationwide. Pharmacy Savings Programs, such as SaveHealth, GoodRx, SingleCare, and WellRx, may help provide important savings to eligible patients. Using SaveHealth, for example, patients may be able to purchase a 30-day...

Serenity Mental Health Centers: Where to Get TMS Therapy in Colorado Springs

they need hope,” said Tricia Pease, COO and co-founder. “Serenity’s call center staff is ready and available to help patients get the care they need, and fast.” Serenity’s outpatient model includes flexible scheduling and same-day appointments,...

Merz Aesthetics® Introduces New BELOTERO® Syringe, Offering Greater Precision, Comfort, and Ease of Use.

long history of empowering health care professionals, patients, and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically...

Fresenius Kabi’s biosimilars Conexxence® and Bomyntra® (denosumab-bnht) receive interchangeable designation from the FDA

supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a...

During FII Week in Riyadh, Rubedo Life Sciences and SVAX announce a strategic partnership

ongoing challenge in the standard of care worldwide. Incorporating study sites at the crossroads of three continents will help provide a more representative overall patient population for the evaluation of RLS-1496 in this important condition.” “At...

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help detect and fight tumor cells. KEYTRUDA is a humanized monoclonal antibody that blocks the interaction between PD-1 and...

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

Chemputation—Chemify’s purpose-built AI to digitize molecule creation—has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. The...

Illumina's Constellation Mapped Read technology uncovers hard-to-see genomic insights in the GeneDx pilot

delays and increase the risk of some childhood cancers. Deep and rapid insights from whole-genome sequencing can help researchers understand and better identify potential treatments for these hard-to-diagnose conditions. Constellation is emerging...

CTIBIOTECH™ Partners with SATT AxLR and CILCARE to Develop Inner Ear Organoids for Hearing Disorder Screening

of CTIBIOTECH™, emphasized the strategic importance of this agreement: "Working alongside CILCARE and SATT AxLR, we are helping to develop tools that will accelerate the discovery of treatments for hearing pathologies affecting more than 1 billion...

FDA Approves ZOLL’s Zenix Monitor/Defibrillator, Elevating Asahi Kasei’s Critical Care Solutions

device with real-time adjustments that make it easy to use in critical moments. The device also features ZOLL’s Real BVM Help® and exclusive Real CPR Help® technology. ZOLL has been a major source of growth for Asahi Kasei’s Healthcare sector,...

Dr. Zivjena Vucetic Appointed as Chief Medical Officer at Mission Bio to Lead Biopharma Partnerships and Clinical Adoption

single-cell multi-omics platform carries the same potential to shift standards in precision medicine, and I am eager to help extend its impact across cancer, cell and gene therapy, and therapeutic development.” Mission Bio’s Tapestri Platform is...

Zifo Executive: Biopharma Faces AI Anxiety and Tech Obsolescence

widespread anxiety, she believes, is moving from a 'wait-and-see' mindset to proactive education and enablement. By helping employees understand that AI is a tool for efficiency, not a threat to their jobs, organizations can unlock its...

Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ Subcutaneous Maintenance Dose for Early Alzheimer's Treatment

journey, from initiation through maintenance therapy. In addition to the current resources already provided (e.g., help with understanding insurance coverage and potential out-of-pocket costs and identifying financial support programs), the new...

Novartis Receives FDA Approval for Rhapsido® (remibrutinib), the First Oral, Targeted BTKi Treatment for Chronic Spontaneous Urticaria (CSU

injections or lab monitoring. It is the first FDA-approved Bruton's tyrosine kinase inhibitor (BTKi) for CSU. Rhapsido helps to inhibit the release of histamine and other proinflammatory mediators by targeting BTK, offering a unique approach to CSU...

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

symptoms in the real world among patients receiving up to 12 months of treatment with DAYBUE. “These findings from LOTUS help deepen our understanding of the potential outcomes associated with long-term treatment of DAYBUE in the real-world...

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

or targeted therapies in preclinical models. TTFields therapy provides clinical versatility that has the potential to help address treatment challenges across a range of solid tumors. About Novocure: Novocure is a global oncology company working to...

At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers

basket study, which includes BRAF V600 altered thyroid cancers, as we aim to generate further data to inform treatment and help patients with BRAF driven tumors.” The results presented at ATA 2025 are from 21 patients with thyroid cancer, 16 with...